Affidea’s Acquisition of Nu-Med

Gide Warsaw advised Enterprise Investors on the sale of Nu-Med Group. Affidea, a leading pan-European provider of specialist healthcare services, including cancer care, advanced diagnostic imaging,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Healx’s $47m Series C Funding Round

Taylor Wessing advised Healx on its funding round. Healx, an AI-enabled, clinical-stage biotech company specializing in rare diseases based in Cambridge UK, has raised $47 million...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

AllBright’s Acquisition of everywoman

Blake Morgan acted for the selling everywoman shareholders. AllBright, a leading global organisation dedicated to advancing women’s careers at all stages, has announced the acquisition of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here